Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions [Yahoo! Finance]
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
41% of the business is held by the top 25 shareholders Institutions own 26% of Eton Pharmaceuticals A look at the shareholders of Eton Pharmaceuticals, Inc. ( NASDAQ:ETON ) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are retail investors with 58% ownership. Put another way, the group faces the maximum upside potential (or downside risk). And institutions on the other hand have a 26% ownership in the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. Let's delve deeper into each type of owner of Eton Pharmaceuticals, beginning with the chart below. View our latest analysis for Eton Pharmaceuticals Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Eton Pharmaceuticals alr
Show less
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)GlobeNewswire
- Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical TrialGlobeNewswire
- Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial OfficerGlobeNewswire
ETON
Earnings
- 11/12/24 - Beat
ETON
Sec Filings
- 12/20/24 - Form 8-K
- 12/17/24 - Form 8-K
- 12/12/24 - Form 8-K
- ETON's page on the SEC website